wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38592363-12B85222-CBA3-4F73-8B37-8426E0D1D6AB
Q38592363-12B85222-CBA3-4F73-8B37-8426E0D1D6AB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38592363-12B85222-CBA3-4F73-8B37-8426E0D1D6AB
Biosimilars in immune-mediated inflammatory diseases: initial lessons from the first approved biosimilar anti-tumour necrosis factor monoclonal antibody.
P2860
Q38592363-12B85222-CBA3-4F73-8B37-8426E0D1D6AB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38592363-12B85222-CBA3-4F73-8B37-8426E0D1D6AB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
548318eeb1ac78c0fba964b7292bdfad0fd79487
P2860
A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study